Author: News Room

ENGLEWOOD, Colo., Dec. 27, 2023 (GLOBE NEWSWIRE) — ONEflight International dazzled attendees with the private aviation company’s annual Black Tie Gala on December 16, sensibly held within ONEflight’s new hangar. The event featured a VIP cocktail reception, star-studded guest list, captivating performances, and exciting announcements throughout the evening. Festivities kicked off with a cocktail hour, setting the stage for an evening of elegance and commemoration. The exclusive VIP reception welcomed several distinguished ONEflight VIP members and brand ambassadors, including Robert Herjavec, Kevin O’Leary, Kevin Costner, Courtney Cox, Kurt Russell, Goldie Hawn, Jason Bateman, Paul Rudd, and Anthony Scaramucci. Members, employees,…

Read More

OWINGS MILLS, MD, Dec. 27, 2023 (GLOBE NEWSWIRE) — A multi-platform media campaign highlighted by a thirty-second TV spot featuring Baltimore Ravens player Morgan Moses, produced by the Maryland State Ad Agency (MSAA) for the Maryland Department of Health’s Behavioral Health Administration (BHA), premiered this month on media outlets across the state. The widely distributed message featuring Moses can be viewed at youtube.com/watch?v=duh0JWo-F0U. The  TV spot and its various iterations are part of a BHA campaign launched in mid-December and continuing through February 2024. The campaign is designed to build awareness about and provide access to information and support for…

Read More

DALLAS, Dec. 27, 2023 (GLOBE NEWSWIRE) — Associa, the community management industry’s largest company, recently held its annual Christmas toy drive in support of North Texas kids. Team members at the Associa Home Office collected and donated 130 toys to Community Partners of Dallas. They were then distributed to kids throughout Dallas County who would otherwise go without a gift this Christmas. This comes on the heels of the company’s recent Big Bike Giveaway, where team members assembled 300 bikes that were also donated to North Texas charities. Thanks to the generosity of Associa’s team members, hundreds of kids in…

Read More

If you suffered losses exceeding $50,000 investing in Lovesac stock or options between March 30, 2023 and August 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/LOVE. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Lovesac Company (“Lovesac” or the “Company”) (NASDAQ: LOVE) and reminds investors of the February 20, 2024 deadline…

Read More

If you suffered losses exceeding $100,000 investing in Estee stock or options between August 18, 2022 and May 2, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EL. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Estée Lauder Companies Inc. (“Estee” or the “Company”) (NYSE: EL) and reminds investors of the February 5,…

Read More

If you suffered losses exceeding $50,000 investing in Outlook securities between August 3, 2021 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/OTLK. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and reminds investors of the January 2, 2024 deadline to seek…

Read More

If you suffered losses exceeding $100,000 investing in Mercury stock or options between December 7, 2020 and June 23, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/MRCY. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Mercury Systems, Inc. (“Mercury” or the “Company”) (NASDAQ: MRCY) and reminds investors of the February 12, 2024 deadline…

Read More

If you suffered losses exceeding $25,000 investing in Brainstorm securities between August 15, 2022 and September 27, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BCLI. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI) and reminds investors of the January 2, 2024 deadline to…

Read More

If you suffered losses exceeding $100,000 investing in General Motors stock or options between February 2, 2022 and October 26, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GM. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against General Motors Company (“General Motors” or the “Company”) (NYSE: GM) and reminds investors of the February 6,…

Read More

If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/EGRX. There is no cost or obligation to you. NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eagle Pharmaceuticals, Inc. (“Eagle Pharmaceuticals” or the “Company”) (NASDAQ: EGRX) and reminds investors of the February 9,…

Read More